Drug intelligence / Profile preview

ICAM-1-targeted microbubbles

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

ICAM-1-targeted microbubbles are ultrasound contrast agents functionalized with antibodies or ligands targeting intercellular adhesion molecule-1 (ICAM-1). These microbubbles are designed for molecular imaging and targeted drug or gene delivery (such as ultrasound-targeted microbubble destruction, or UTMD) in inflammatory and cardiovascular conditions, including atherosclerosis, myocardial infarction, and autoimmune encephalitis. By binding specifically to ICAM-1 expressed on activated endothelial cells, they allow non-invasive, real-time ultrasound visualization of vascular inflammation and localized therapeutic delivery when combined with ultrasound pulses.

Other names
anti-ICAM-1 microbubblesanti-ICAM1 microbubblesanti-ICAM 1 microbubblesICAM-1-targeted microbubbleICAM1-targeted microbubbleICAM 1-targeted microbubbleintercellular adhesion molecule-1-targeted microbubbles
02

Targets

ICAM1 (Intercellular Adhesion Molecule 1)

Beyond the preview

Go deeper on ICAM-1-targeted microbubbles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ICAM-1-targeted microbubbles.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call